LIVER INTERNATIONAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0 经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574581, encodeId=05485e458172, content=审稿速度:1.0 经验分享：1周编辑直接拒稿，还是很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/icbuVVg9Oia8k7XvKROVv4SDLticUY7sKbmXHibAUhSHnJ1rcsMtw88ibVfxPiaJJkp28hic11ficEZianymliaKWwjtIZ8Q/132, createdBy=3b681984931, createdName=老男孩xz, createdTime=Thu Aug 08 22:29:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581599, encodeId=52ed5815993f, content=刚中了一篇，中科院分区小类三区了，真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474619, encodeId=c9364e461938, content=《国际肝杂志》刊载肝功能和肝病研究，包括形态、生理、免疫及临床研究方面的论文，兼载书评、学术界动态报道等。 英文关键词：Gastroenterology 中文关键词：胃肠病学, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7c34764, createdName=marshlin, createdTime=Mon Mar 28 17:46:00 CST 2011, time=2011-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢dujiang 2019-12-19 发表:: 8月19投，11月25接收dujiang 2019-12-19 00:00:00 发表: 8月19投，11月25接收, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581830, encodeId=b13a5818307c, content=不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了dujiang 2019-12-16 00:00:00 发表: 刚中了一篇，中科院分区小类三区了，真服了, beContent=dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]

2021-03-01 缅怀21世纪

投稿命中率:25.0
经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject

100 0

[GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0 经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574581, encodeId=05485e458172, content=审稿速度:1.0 经验分享：1周编辑直接拒稿，还是很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/icbuVVg9Oia8k7XvKROVv4SDLticUY7sKbmXHibAUhSHnJ1rcsMtw88ibVfxPiaJJkp28hic11ficEZianymliaKWwjtIZ8Q/132, createdBy=3b681984931, createdName=老男孩xz, createdTime=Thu Aug 08 22:29:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581599, encodeId=52ed5815993f, content=刚中了一篇，中科院分区小类三区了，真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474619, encodeId=c9364e461938, content=《国际肝杂志》刊载肝功能和肝病研究，包括形态、生理、免疫及临床研究方面的论文，兼载书评、学术界动态报道等。 英文关键词：Gastroenterology 中文关键词：胃肠病学, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7c34764, createdName=marshlin, createdTime=Mon Mar 28 17:46:00 CST 2011, time=2011-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢dujiang 2019-12-19 发表:: 8月19投，11月25接收dujiang 2019-12-19 00:00:00 发表: 8月19投，11月25接收, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581830, encodeId=b13a5818307c, content=不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了dujiang 2019-12-16 00:00:00 发表: 刚中了一篇，中科院分区小类三区了，真服了, beContent=dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]

2019-08-08 老男孩xz

审稿速度:1.0
经验分享：1周编辑直接拒稿，还是很快

149 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0 经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574581, encodeId=05485e458172, content=审稿速度:1.0 经验分享：1周编辑直接拒稿，还是很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/icbuVVg9Oia8k7XvKROVv4SDLticUY7sKbmXHibAUhSHnJ1rcsMtw88ibVfxPiaJJkp28hic11ficEZianymliaKWwjtIZ8Q/132, createdBy=3b681984931, createdName=老男孩xz, createdTime=Thu Aug 08 22:29:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581599, encodeId=52ed5815993f, content=刚中了一篇，中科院分区小类三区了，真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474619, encodeId=c9364e461938, content=《国际肝杂志》刊载肝功能和肝病研究，包括形态、生理、免疫及临床研究方面的论文，兼载书评、学术界动态报道等。 英文关键词：Gastroenterology 中文关键词：胃肠病学, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7c34764, createdName=marshlin, createdTime=Mon Mar 28 17:46:00 CST 2011, time=2011-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢dujiang 2019-12-19 发表:: 8月19投，11月25接收dujiang 2019-12-19 00:00:00 发表: 8月19投，11月25接收, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581830, encodeId=b13a5818307c, content=不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了dujiang 2019-12-16 00:00:00 发表: 刚中了一篇，中科院分区小类三区了，真服了, beContent=dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]

2019-12-16 dujiang

刚中了一篇，中科院分区小类三区了，真服了

152 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0 经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574581, encodeId=05485e458172, content=审稿速度:1.0 经验分享：1周编辑直接拒稿，还是很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/icbuVVg9Oia8k7XvKROVv4SDLticUY7sKbmXHibAUhSHnJ1rcsMtw88ibVfxPiaJJkp28hic11ficEZianymliaKWwjtIZ8Q/132, createdBy=3b681984931, createdName=老男孩xz, createdTime=Thu Aug 08 22:29:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581599, encodeId=52ed5815993f, content=刚中了一篇，中科院分区小类三区了，真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474619, encodeId=c9364e461938, content=《国际肝杂志》刊载肝功能和肝病研究，包括形态、生理、免疫及临床研究方面的论文，兼载书评、学术界动态报道等。 英文关键词：Gastroenterology 中文关键词：胃肠病学, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7c34764, createdName=marshlin, createdTime=Mon Mar 28 17:46:00 CST 2011, time=2011-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢dujiang 2019-12-19 发表:: 8月19投，11月25接收dujiang 2019-12-19 00:00:00 发表: 8月19投，11月25接收, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581830, encodeId=b13a5818307c, content=不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了dujiang 2019-12-16 00:00:00 发表: 刚中了一篇，中科院分区小类三区了，真服了, beContent=dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]

2011-03-28 marshlin

《国际肝杂志》刊载肝功能和肝病研究，包括形态、生理、免疫及临床研究方面的论文，兼载书评、学术界动态报道等。
英文关键词：Gastroenterology
中文关键词：胃肠病学

462 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0 经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574581, encodeId=05485e458172, content=审稿速度:1.0 经验分享：1周编辑直接拒稿，还是很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/icbuVVg9Oia8k7XvKROVv4SDLticUY7sKbmXHibAUhSHnJ1rcsMtw88ibVfxPiaJJkp28hic11ficEZianymliaKWwjtIZ8Q/132, createdBy=3b681984931, createdName=老男孩xz, createdTime=Thu Aug 08 22:29:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581599, encodeId=52ed5815993f, content=刚中了一篇，中科院分区小类三区了，真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474619, encodeId=c9364e461938, content=《国际肝杂志》刊载肝功能和肝病研究，包括形态、生理、免疫及临床研究方面的论文，兼载书评、学术界动态报道等。 英文关键词：Gastroenterology 中文关键词：胃肠病学, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7c34764, createdName=marshlin, createdTime=Mon Mar 28 17:46:00 CST 2011, time=2011-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢dujiang 2019-12-19 发表:: 8月19投，11月25接收dujiang 2019-12-19 00:00:00 发表: 8月19投，11月25接收, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581830, encodeId=b13a5818307c, content=不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了dujiang 2019-12-16 00:00:00 发表: 刚中了一篇，中科院分区小类三区了，真服了, beContent=dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]

2020-05-08 12107b02m29(暂无昵称)

审稿速度:1.0 | 投稿命中率:5.0
经验分享：三百多例样本量的临床研究被认为小样本，秒拒

107 0

[GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0 经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574581, encodeId=05485e458172, content=审稿速度:1.0 经验分享：1周编辑直接拒稿，还是很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/icbuVVg9Oia8k7XvKROVv4SDLticUY7sKbmXHibAUhSHnJ1rcsMtw88ibVfxPiaJJkp28hic11ficEZianymliaKWwjtIZ8Q/132, createdBy=3b681984931, createdName=老男孩xz, createdTime=Thu Aug 08 22:29:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581599, encodeId=52ed5815993f, content=刚中了一篇，中科院分区小类三区了，真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474619, encodeId=c9364e461938, content=《国际肝杂志》刊载肝功能和肝病研究，包括形态、生理、免疫及临床研究方面的论文，兼载书评、学术界动态报道等。 英文关键词：Gastroenterology 中文关键词：胃肠病学, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7c34764, createdName=marshlin, createdTime=Mon Mar 28 17:46:00 CST 2011, time=2011-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢dujiang 2019-12-19 发表:: 8月19投，11月25接收dujiang 2019-12-19 00:00:00 发表: 8月19投，11月25接收, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581830, encodeId=b13a5818307c, content=不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了dujiang 2019-12-16 00:00:00 发表: 刚中了一篇，中科院分区小类三区了，真服了, beContent=dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]

2020-03-22 wxsessionb9467e4a

近一年一审要多久，这次会不会因疫情耽搁？

103 0

[GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0 经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574581, encodeId=05485e458172, content=审稿速度:1.0 经验分享：1周编辑直接拒稿，还是很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/icbuVVg9Oia8k7XvKROVv4SDLticUY7sKbmXHibAUhSHnJ1rcsMtw88ibVfxPiaJJkp28hic11ficEZianymliaKWwjtIZ8Q/132, createdBy=3b681984931, createdName=老男孩xz, createdTime=Thu Aug 08 22:29:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581599, encodeId=52ed5815993f, content=刚中了一篇，中科院分区小类三区了，真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474619, encodeId=c9364e461938, content=《国际肝杂志》刊载肝功能和肝病研究，包括形态、生理、免疫及临床研究方面的论文，兼载书评、学术界动态报道等。 英文关键词：Gastroenterology 中文关键词：胃肠病学, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7c34764, createdName=marshlin, createdTime=Mon Mar 28 17:46:00 CST 2011, time=2011-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢dujiang 2019-12-19 发表:: 8月19投，11月25接收dujiang 2019-12-19 00:00:00 发表: 8月19投，11月25接收, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581830, encodeId=b13a5818307c, content=不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了dujiang 2019-12-16 00:00:00 发表: 刚中了一篇，中科院分区小类三区了，真服了, beContent=dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]

2019-12-29 阿丫丫

请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创

35 0

[GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0 经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574581, encodeId=05485e458172, content=审稿速度:1.0 经验分享：1周编辑直接拒稿，还是很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/icbuVVg9Oia8k7XvKROVv4SDLticUY7sKbmXHibAUhSHnJ1rcsMtw88ibVfxPiaJJkp28hic11ficEZianymliaKWwjtIZ8Q/132, createdBy=3b681984931, createdName=老男孩xz, createdTime=Thu Aug 08 22:29:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581599, encodeId=52ed5815993f, content=刚中了一篇，中科院分区小类三区了，真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474619, encodeId=c9364e461938, content=《国际肝杂志》刊载肝功能和肝病研究，包括形态、生理、免疫及临床研究方面的论文，兼载书评、学术界动态报道等。 英文关键词：Gastroenterology 中文关键词：胃肠病学, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7c34764, createdName=marshlin, createdTime=Mon Mar 28 17:46:00 CST 2011, time=2011-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢dujiang 2019-12-19 发表:: 8月19投，11月25接收dujiang 2019-12-19 00:00:00 发表: 8月19投，11月25接收, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581830, encodeId=b13a5818307c, content=不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了dujiang 2019-12-16 00:00:00 发表: 刚中了一篇，中科院分区小类三区了，真服了, beContent=dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]

2019-12-20 Dr.liang1003

非常感谢dujiang 2019-12-19 发表::
8月19投，11月25接收dujiang 2019-12-19 00:00:00 发表:
8月19投，11月25接收

dujiang 2019-12-19 发表:: 8月19投，11月25接收

112 0

[GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0 经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574581, encodeId=05485e458172, content=审稿速度:1.0 经验分享：1周编辑直接拒稿，还是很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/icbuVVg9Oia8k7XvKROVv4SDLticUY7sKbmXHibAUhSHnJ1rcsMtw88ibVfxPiaJJkp28hic11ficEZianymliaKWwjtIZ8Q/132, createdBy=3b681984931, createdName=老男孩xz, createdTime=Thu Aug 08 22:29:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581599, encodeId=52ed5815993f, content=刚中了一篇，中科院分区小类三区了，真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474619, encodeId=c9364e461938, content=《国际肝杂志》刊载肝功能和肝病研究，包括形态、生理、免疫及临床研究方面的论文，兼载书评、学术界动态报道等。 英文关键词：Gastroenterology 中文关键词：胃肠病学, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7c34764, createdName=marshlin, createdTime=Mon Mar 28 17:46:00 CST 2011, time=2011-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢dujiang 2019-12-19 发表:: 8月19投，11月25接收dujiang 2019-12-19 00:00:00 发表: 8月19投，11月25接收, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581830, encodeId=b13a5818307c, content=不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了dujiang 2019-12-16 00:00:00 发表: 刚中了一篇，中科院分区小类三区了，真服了, beContent=dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]

2019-12-19 dujiang

8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表:
不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……

Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……

117 0

[GetPortalCommentsPageByObjectIdResponse(id=944420, encodeId=e23a94442026, content=投稿命中率:25.0 经验分享：头天下午投稿马上显示under review，第二天早上醒来直接被reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45bf2312999, createdName=缅怀21世纪, createdTime=Mon Mar 01 13:01:42 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574581, encodeId=05485e458172, content=审稿速度:1.0 经验分享：1周编辑直接拒稿，还是很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/icbuVVg9Oia8k7XvKROVv4SDLticUY7sKbmXHibAUhSHnJ1rcsMtw88ibVfxPiaJJkp28hic11ficEZianymliaKWwjtIZ8Q/132, createdBy=3b681984931, createdName=老男孩xz, createdTime=Thu Aug 08 22:29:00 CST 2019, time=2019-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581599, encodeId=52ed5815993f, content=刚中了一篇，中科院分区小类三区了，真服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Mon Dec 16 00:00:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474619, encodeId=c9364e461938, content=《国际肝杂志》刊载肝功能和肝病研究，包括形态、生理、免疫及临床研究方面的论文，兼载书评、学术界动态报道等。 英文关键词：Gastroenterology 中文关键词：胃肠病学, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e7c34764, createdName=marshlin, createdTime=Mon Mar 28 17:46:00 CST 2011, time=2011-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590466, encodeId=70dc59046653, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三百多例样本量的临床研究被认为小样本，秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587147, encodeId=76de58e147a7, content=近一年一审要多久，这次会不会因疫情耽搁？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib0MTGXCbVubxiaZIicmkGvQBPicpFB3LlYQtvCkn8fj6iaczhe3URcAqZjTsVXqZq6O36LxUyXHIOiaSp5BU8sjInDQF/0, createdBy=33671972820, createdName=wxsessionb9467e4a, createdTime=Sun Mar 22 06:03:00 CST 2020, time=2020-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582349, encodeId=143258234917, content=请问各位大侠，这个杂志需要提供患者签字的知情同意书嘛？如果是回顾性研究么，完全无创, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/7MZxBj3Bp9LFylDIwTx9Aibm3icNfevAibDxyXmlnlU06rGblZAwOKic5bYiaFgB9RYgdJ0EicictypVDIoCpP1hbarHA/132, createdBy=174c1670703, createdName=阿丫丫, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581843, encodeId=4f3458184397, content=非常感谢dujiang 2019-12-19 发表:: 8月19投，11月25接收dujiang 2019-12-19 00:00:00 发表: 8月19投，11月25接收, beContent=dujiang 2019-12-19 发表:: 8月19投，11月25接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Fri Dec 20 00:00:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581833, encodeId=1c78581833a7, content=8月19投，11月25接收Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, beContent=Dr.liang1003 2019-12-19 00:00:00 发表: 不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLaYGcq2jR8ySEWalFlEicicYzD5he3CJZ4qCCKibxsk54QPWpWyolIvG4cUgKOacP1B28qsAiarh5wOA/132, createdBy=277d2215936, createdName=dujiang, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581830, encodeId=b13a5818307c, content=不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了dujiang 2019-12-16 00:00:00 发表: 刚中了一篇，中科院分区小类三区了，真服了, beContent=dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MMxbq4GKvwKXuygVVZGkPsQ8kiaZUib9NLKibED0LQSnxvMarBibIumiaIhsg8kH7ZHWvUPb8XhG5jqg20VBdCQePiag/132, createdBy=1ec21992614, createdName=Dr.liang1003, createdTime=Thu Dec 19 00:00:00 CST 2019, time=2019-12-19, status=1, ipAttribution=)]

2019-12-19 Dr.liang1003

不好意思，想问一下，您审稿花了多长时间，10.31投稿一篇，现在还是审稿状态……dujiang 2019-12-16 发表::
刚中了一篇，中科院分区小类三区了，真服了dujiang 2019-12-16 00:00:00 发表:
刚中了一篇，中科院分区小类三区了，真服了

dujiang 2019-12-16 发表:: 刚中了一篇，中科院分区小类三区了，真服了

90 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务